Summary
Amends the
Therapeutic Goods Act 1989
to: introduce mandatory reporting requirements for sponsors of mainly prescription medicines to report shortages of, and any decision to permanently discontinue, their products; and make miscellaneous amendments in relation to: enabling standards to adopt other documents as in force from time to time; enabling the Secretary to require priority pathway applicants to provide supporting information; streamlining of health practitioner notifications under the Special Access Scheme and certain advertising requirements; variations to registered medicines through notification; and a minor technical amendment.